Genpact Limited (NYSE:G – Get Free Report) has received a consensus rating of “Hold” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $42.33.
Several research firms recently issued reports on G. TD Cowen increased their target price on Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research report on Friday, November 8th. Needham & Company LLC increased their price objective on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Finally, Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th.
Get Our Latest Stock Report on Genpact
Genpact Stock Up 1.4 %
Genpact Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, December 23rd. Stockholders of record on Monday, December 9th were paid a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend was Monday, December 9th. Genpact’s dividend payout ratio is presently 16.76%.
Insiders Place Their Bets
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 23,058 shares of company stock worth $1,044,715 in the last ninety days. 2.80% of the stock is owned by company insiders.
Institutional Trading of Genpact
A number of institutional investors have recently modified their holdings of the company. Natixis Advisors LLC boosted its position in shares of Genpact by 2.9% in the 2nd quarter. Natixis Advisors LLC now owns 111,132 shares of the business services provider’s stock worth $3,577,000 after purchasing an additional 3,101 shares in the last quarter. Custom Index Systems LLC purchased a new stake in shares of Genpact during the second quarter worth about $416,000. Caprock Group LLC acquired a new position in shares of Genpact during the second quarter valued at about $238,000. Ballentine Partners LLC raised its position in shares of Genpact by 22.0% in the 2nd quarter. Ballentine Partners LLC now owns 14,377 shares of the business services provider’s stock valued at $463,000 after purchasing an additional 2,594 shares during the last quarter. Finally, United Services Automobile Association boosted its stake in Genpact by 3.3% in the 2nd quarter. United Services Automobile Association now owns 13,388 shares of the business services provider’s stock worth $431,000 after purchasing an additional 433 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- Canadian Penny Stocks: Can They Make You Rich?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- 3 Best Fintech Stocks for a Portfolio Boost
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- The 3 Best Retail Stocks to Shop for in August
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.